20 May 2013
Keywords: lilly, licenses, icos, viagra, clone, eli, weighed
Article | 06 October 1998
Eli Lilly has weighed in with a hefty $75 million commitment to securerights to an orally-active phosphodiesterase type V inhibitor for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.